CarmenMagdalenaStancaMD
Gastroenterology • Plano, TXHepatology & Liver Transplantation
Transplant Hepatologist
Dr. Stanca is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4708 Alliance Blvd
Pavillion I, Suite 240
Plano, TX 75093
Summary
- Dr. Carmen Stanca is a hepatologist in Plano, Texas and is affiliated with Baylor Scott & White. She received her medical degree from Carol Davila University of Medicine and Pharmacy. She specializes in hepatology & liver transplantation.
Education & Training
Brooklyn Hospital CenterFellowship, Gastroenterology, 2011 - 2014
Icahn School of Medicine at Mount SinaiFellowship, Transplant Hepatology, 2010 - 2011
NYU Grossman School of Medicine/Brooklyn CampusResidency, Internal Medicine, 2007 - 2010
Carol Davila University of Medicine and PharmacyClass of 1991
Certifications & Licensure
TX State Medical License 2021 - 2026
NY State Medical License 2010 - 2022- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Clinical Trials
- A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis Start of enrollment: 2016 Oct 01
- Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) Start of enrollment: 2017 Dec 12
- ENHANCE: Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA) Start of enrollment: 2018 Oct 01
Publications & Presentations
PubMed
- 36 citationsA phase II, randomized, open-label, 52-week study of seladelpar in patients with primary biliary cholangitis.Christopher L Bowlus, Michael R Galambos, Richard J Aspinall, Gideon M Hirschfield, David E J Jones
Journal of Hepatology. 2022-08-01 - 67 citationsCholangiopathy After Severe COVID-19: Clinical Features and Prognostic Implications.Saamia Faruqui, Fidelis C. Okoli, Sonja Olsen, David M. Feldman, Harmit Kalia
The American Journal of Gastroenterology. 2021-07-01 - 3 citationsThe dynamic and clinical significance of autoantibodies and immunoglobulins in liver transplant recipients.Carmen M. Stanca, Costica Aloman, Maria Isabel Fiel, Kaiser Raja, Oğuz Üsküdar
Clinical Transplantation. 2016-03-01
Professional Memberships
- Member
- American Association for the Study of Liver DiseasesMember
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
